AMIX — Autonomix Medical Balance Sheet
0.000.00%
Annual balance sheet for Autonomix Medical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 2.04 | 0.865 | 8.61 | 9.14 | 7 |
| Total Other Current Assets | |||||
| Total Current Assets | 2.05 | 0.865 | 9.39 | 9.61 | 7.58 |
| Net Property, Plant And Equipment | — | — | 0.016 | 0.021 | 0.019 |
| Other Long Term Assets | |||||
| Total Assets | 2.05 | 0.865 | 9.41 | 9.81 | 7.6 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 0.093 | 0.221 | 0.777 | 1.71 | 1.71 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.093 | 0.221 | 1.78 | 1.71 | 1.71 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 1.96 | 0.644 | 7.63 | 8.1 | 5.89 |
| Total Liabilities & Shareholders' Equity | 2.05 | 0.865 | 9.41 | 9.81 | 7.6 |
| Total Common Shares Outstanding |